LeadIQ logo
Learn more at LeadIQ.com

Insights

Merger for growth Magenta Therapeutics recently merged with Dianthus Therapeutics, indicating potential growth opportunities through expanded resources and capabilities resulting from the merger.

Innovative drug pipeline With a focus on developing a pipeline of drugs to enhance bone marrow transplant processes, Magenta offers sales opportunities in offering groundbreaking solutions for various medical conditions, such as multiple sclerosis and leukemia.

Financial backing Securing significant funding of $86.4 million in private placement financing showcases financial stability, indicating an increased potential for sales growth and investment in innovative solutions.

Key executive appointment The appointment of Jeffrey Humphrey as Chief Medical Officer brings seasoned leadership to the company, presenting opportunities for business development through strategic clinical development and regulatory initiatives.

Targeted therapy development Magenta's focus on developing targeted conditioning agents like MGTA-117 for genetic diseases presents sales opportunities in specialized therapeutic options, catering to niche patient populations and expanding market reach.

Magenta Therapeutics Tech Stack

Magenta Therapeutics uses 8 technology products and services including Google Analytics, Akamai, Shopify, and more. Explore Magenta Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Akamai
    Content Delivery Network
  • Shopify
    E-commerce
  • Google Font API
    Font Scripts
  • HSTS
    Security
  • Akamai Bot Manager
    Security
  • MediaElement.js
    Video Players
  • Nginx
    Web Servers

Media & News

Magenta Therapeutics's Email Address Formats

Magenta Therapeutics uses at least 1 format(s):
Magenta Therapeutics Email FormatsExamplePercentage
FLast@magentatx.comJDoe@magentatx.com
50%
FLast@magentatx.comJDoe@magentatx.com
50%

Frequently Asked Questions

Where is Magenta Therapeutics's headquarters located?

Minus sign iconPlus sign iconMagenta Therapeutics's main headquarters is located at 100 Technology Sq Cambridge, Massachusetts 02139 US. The company has employees across 2 continents, including North AmericaEurope.

What is Magenta Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Magenta Therapeutics's main corporate office by phone at
+1-857-201-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Magenta Therapeutics's stock symbol?

Minus sign iconPlus sign iconMagenta Therapeutics is a publicly traded company; the company's stock symbol is DNTH.

What is Magenta Therapeutics's official website and social media links?

Minus sign iconPlus sign iconMagenta Therapeutics's official website is magentatx.com and has social profiles on LinkedIn.

How much revenue does Magenta Therapeutics generate?

Minus sign iconPlus sign icon As of May 2024, Magenta Therapeutics's annual revenue reached $15M.

What is Magenta Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconMagenta Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Magenta Therapeutics have currently?

Minus sign iconPlus sign iconAs of May 2024, Magenta Therapeutics has approximately 51 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Biometrics: J. L.Head Of Quality: N. M. C.Head Of Intellectual Property: W. N.. Explore Magenta Therapeutics's employee directory with LeadIQ.

What industry does Magenta Therapeutics belong to?

Minus sign iconPlus sign iconMagenta Therapeutics operates in the Biotechnology Research industry.

What technology does Magenta Therapeutics use?

Minus sign iconPlus sign iconMagenta Therapeutics's tech stack includes Google AnalyticsAkamaiShopifyGoogle Font APIHSTSAkamai Bot ManagerMediaElement.jsNginx.

What is Magenta Therapeutics's email format?

Minus sign iconPlus sign iconMagenta Therapeutics's email format typically follows the pattern of . Find more Magenta Therapeutics email formats with LeadIQ.

How much funding has Magenta Therapeutics raised to date?

Minus sign iconPlus sign icon As of May 2024, Magenta Therapeutics has raised $86M in funding. The last funding round occurred on May 12, 2021 for $86M.

When was Magenta Therapeutics founded?

Minus sign iconPlus sign iconMagenta Therapeutics was founded in 2016.
Magenta Therapeutics

Magenta Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

Section iconCompany Overview

Headquarters
100 Technology Sq Cambridge, Massachusetts 02139 US
Phone number
+1-857-201-****
Website
magentatx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DNTH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $86M

    Magenta Therapeutics has raised a total of $86M of funding over 6 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $86M.

  • $10M$50M

    Magenta Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $86M

    Magenta Therapeutics has raised a total of $86M of funding over 6 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $86M.

  • $10M$50M

    Magenta Therapeutics's revenue is in the range of $10M$50M

Company Leadership

  • Stylized image of a person
    J. L.
    Vice President Biometrics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. M. C.
    Head Of Quality
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. N.
    Head Of Intellectual Property
    Phone icon
    Mobile Phone
  • Stylized image of a person
    X. C.
    Head Of Regulatory Cmc
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. S.
    Co-Founder And Director
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    W. N.
    Head Of Intellectual Property
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. S.
    Vp- Head Of Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    X. C.
    Head Of Regulatory Cmc
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. C.
    Associate Director, Corporate Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. A.
    Director, Supply Chain
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.